Additional Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury

Clinical trial NCT07722962 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07722962
Sponsor: Kringle Pharma, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Spinal Cord Injury (SCI)

Start date: 2026-07-31
Primary completion: 2028-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.